日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer

通路活性分析可以预测HR+ HER2-绝经后早期乳腺癌新辅助内分泌治疗的反应

de Gruil, N; de Groot, A F; Wesseling-Rozendaal, Y; Keizer, D; Koekenbier, C S; Vermeer, S; Cohen, D; Heijns, J B; Mandigers, C M P W; van de Wouw, A J; Cloos-van Balen, M; Ropela, J A; Oosterkamp, H M; van Bekkum, M L; Houtsma, D; Biezen, E den; Liefers, G J; Linn, S C; Kroep, J R

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

三氟尿苷-替吡嘧啶治疗既往接受过治疗的雌激素受体阳性、HER2阴性转移性乳腺癌患者(BOOG 2019-01 TIBET试验):一项单臂、多中心、II期试验

Guchelaar, Niels A D; Mathijssen, Ron H J; de Boer, Maaike; van Bekkum, Marlies L; Heijns, Joan B; Vriens, Birgit E P J; van Rosmalen, Mandy M; Kessels, Lonneke W; Hamming, Lisanne; Beelen, Karin J; Nieboer, Peter; van den Berg, Susan M; Hoop, Esther Oomen-de; Bijlsma, Rhodé M; Bos, Monique E M M

Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study

HER2阳性转移性乳腺癌患者的完全缓解:一项真实世界的SONABRE研究

Ding, Nan; Visserman, Renee; Geurts, Sandra M E; Tol, Jolien; Vriens, Birgit E P J; Aaldering, Kirsten N A; Boon, Eline; Dercksen, Marcus W; van den Berkmortel, Franchette; Pepels, Manon J A E; Peters, Natascha A J B; Heijns, Joan B; van de Winkel, Linda; de Fallois, Aude J O; Tjan-Heijnen, Vivianne C G; de Boer, Maaike

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

BMI对HR+/HER2-晚期乳腺癌患者预后的影响:一项基于SONABRE注册研究的分析

Lammers, Senna W M; Thurisch, Hannah; Vriens, Ingeborg J H; Meegdes, Marissa; Engelen, Sanne M E; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Peters, Natascha A J B; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Teeuwen, Nathalie J A; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

SONABRE注册研究分析了新诊断为HER2阳性转移性乳腺癌患者的真实世界治疗模式和生存期的时间趋势。

Geurts, Sandra M E; Ibragimova, Khava I E; Ding, Nan; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; van de Wouw, Agnes J; Maaskant, Sabrina A J G; Teeuwen-Dedroog, Nathalie J A; van Nijnatten, Thiemo J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

在接受一线治疗的HR阳性、HER2阴性转移性乳腺癌患者中,采用mFAST-SeqS检测肿瘤非依赖性ctDNA水平作为生存生物标志物

Verschoor, Noortje; de Weerd, Vanja; Van, Mai N; Kraan, Jaco; Smid, Marcel; Heijns, Joan B; Drooger, Jan C; Zuetenhorst, Johanna M; van der Padt-Pruijsten, Annemieke; Jager, Agnes; Sleijfer, Stefan; Martens, John W M; Wilting, Saskia M

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

HER2阳性晚期乳腺癌患者前四线治疗的疗效:来自SONABRE注册研究的结果

Ibragimova, Khava I E; Geurts, Sandra M E; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; Teeuwen-Dedroog, Nathalie J A; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G

Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer

开发晚期癌症患者一年死亡率临床预测模型

Owusuaa, Catherine; van der Padt-Pruijsten, Annemieke; Drooger, Jan C; Heijns, Joan B; Dietvorst, Anne-Marie; Janssens-van Vliet, Ellen C J; Nieboer, Daan; Aerts, Joachim G J V; van der Heide, Agnes; van der Rijt, Carin C D

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

初始激素受体/HER2亚型是晚期乳腺癌亚型不一致的主要决定因素:一项基于SONABRE登记研究的调查。

Meegdes, Marissa; Ibragimova, Khava I E; Lobbezoo, Dorien J A; Vriens, Ingeborg J H; Kooreman, Loes F S; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Peters, Natascha A J B; Hochstenbach-Waelen, Ananda; Smidt, Marjolein L; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study

乳腺癌新辅助化疗后无病生存期和总生存期:一项大型单中心队列研究比较保乳手术与乳房切除术

Simons, Janine M; Jacobs, Julien G; Roijers, Joost P; Beek, Maarten A; Boonman-de Winter, Leandra J M; Rijken, Arjen M; Gobardhan, Paul D; Wijsman, Jan H; Tetteroo, Eric; Heijns, Joan B; Yick, C Y; Luiten, Ernest J T